Jing Lu has joined Shihui Partners in Beijing as a partner. He specializes in data compliance, anti-bribery compliance and various life sciences-related transactions and collaboration projects.
Lu has extensive experience in the life sciences industry. His clients include both foreign-invested enterprises (Pfizer, Bayer, AstraZeneca, Gilead, Medtronic, Olympus) and China-based innovative companies (BeiGene, Overland Pharma, Adagene, Evaheart). Lu has advised clients on data compliance and anti-bribery compliance system readiness, assessment of compliance system effectiveness, conducting compliance due diligence for M&A deals, conducting internal investigations against employees, and representing companies in business negotiations, due diligence and contract drafting as well as legal and compliance advice in connection various transactions and collaboration projects, such as product license-in deals, contract sales organization deals, broad market projects, retail collaboration projects, patient assistance programmes and digital platform programmes.
Before joining Shihui, Lu was a counsel at Sidley Austin, where he was a core member of its China life sciences team for many years, and a lawyer at Paul Hastings. He is admitted to practice in New York.